Tyra Biosciences, Inc. (TYRA) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-02-13

Key Insights

The reporting person, Daniel Bensen, who is the Chief Discovery Officer, sold 8,000 shares of the company's common stock on February 12, 2026 pursuant to a Rule 10b5-1 trading plan.
The total number of shares beneficially owned by the reporting person following the reported transactions is 146,981 shares.
The reporting person sold the shares at an average price of $31.50 and $33.37 per share, indicating potential insider selling activity.

Want the newest filings?

This analysis covers the filing from 2026-02-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-20

The reporting person, Daniel Bensen, who is the Chief Discovery Officer of Tyra Biosciences, Inc. (TYRA), sold 8,000 shares of the company's common stock on 01/12/2026 under a pre-established Rule 10b5-1 trading plan.
The sale was executed at a weighted average price of $28.44 and $29.08 per share, resulting in a total sale of approximately $232,000.
Following the reported transaction, the reporting person still holds 154,981 shares of the company's common stock, indicating continued ownership and commitment to the company.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.